Terms and Conditions

Recent News in Senolytics

• 
  The Senolytics Showdown: Unpacking the Recent Controversy

  Apr 19, 2024 | Senolytic News
• 
  The Promise of Senolytic Therapies

  Oct 2, 2023 | Senolytic News
• 
  AI Unlocks New Frontier in Anti-Aging Medicine

  Aug 24, 2023 | Senolytic News
• 
  Reversing Aging in Stem Cells

  Jun 29, 2023 | Uncategorized
• 
  Fighting aging with immune checkpoint blockade

  Nov 23, 2022 | Senolytic News
• 
  Despite Their Scary Name, Some ‘Zombie’ Cells May Not Be All Bad

  Nov 23, 2022 | Senolytic News
• 
  Focus on frailty: New senolytic holds potential for sarcopenia treatment

  Nov 22, 2022 | Senolytic News
• 
  Progress in Emerging Alzheimer’s Therapeutics Based on Biology of Aging to be Highlighted in Session Moderated by Alzheimer’s Drug Discovery Foundation (ADDF) at 2022 Clinical Trials on Alzheimer’s Disease Conference

  Nov 21, 2022 | Senolytic News
• 
  Senolytic treatment shows promise in DME, wet AMD

  Nov 20, 2022 | Senolytic News
• 
  Global Senolytic Drugs Market Research Report 2022: Voice of Customer, Clinical Trials, Patent Analysis, Outlook, Market Dynamics, Trends & Developments, Competitive Landscape

  Nov 19, 2022 | Senolytic News
• 
  A Glb1-2A-mCherry reporter monitors systemic aging and predicts lifespan in middle-aged mice

  Nov 19, 2022 | Senolytic News
• 
  Senolytics to Tackle Age-Related Pathologies

  Nov 19, 2022 | Senolytic News